DNA and RNA sample preparation market

Introduction By 2032, the DNA and RNA sample preparation market is projected to reach US$ 3.11 billion, up from US$ 2.12 billion in 2025, with a CAGR of 5.7%. Persistence Market Research (PMR) states that rising infectious disease cases and innovative product launches will accelerate market expansion. DNA and RNA preparation play a crucial role in diagnosing illnesses like pneumonia, hepatitis, and AIDS. The global DNA & RNA sample processing market is experiencing rapid growth, driven by advancements in genomics, rising demand for precision medicine, and increased research in molecular diagnostics. As biotechnology and pharmaceutical industries expand their focus on genetic research, the need for efficient sample processing solutions has surged. By 2025, the market is projected to exceed $2.12 billion, fueled by technological innovations, increased healthcare funding, and the growing adoption of next-generation sequencing (NGS) techniques. Key Growth Drivers Rising Demand for Precision Medicine Precision medicine, which tailors treatment based on an individual's genetic profile, is revolutionizing healthcare. DNA and RNA sample processing plays a crucial role in this approach, enabling accurate disease diagnosis and personalized therapy development. The increasing prevalence of cancer, genetic disorders, and infectious diseases has further accelerated the demand for high-quality nucleic acid extraction and processing technologies.